Literature DB >> 17625931

Matrix metalloproteinases at cancer tumor-host interface.

Agnès Noël1, Maud Jost, Erik Maquoi.   

Abstract

The increasing diversity in both substrates and functions of matrix metalloproteinases (MMPs) makes these enzymes central regulators in the complex tumor ecosystem composed of cancer cells and their microenvironment. In the majority of cancers, membrane-associated and extracellular proteases are mainly produced by host cells including inflammatory cells, endothelial cells, pericytes and fibroblasts. Recent data based on in vitro and in vivo studies have demonstrated the relevance of these enzymes in multiple processes controlling cancer growth, angiogenesis and metastatic dissemination. This review will present the emerging MMP-related features of cancer cells and host cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625931     DOI: 10.1016/j.semcdb.2007.05.011

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  82 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

Review 3.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

4.  The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.

Authors:  N Rocks; C Estrella; G Paulissen; F Quesada-Calvo; C Gilles; M M Guéders; C Crahay; J-M Foidart; P Gosset; A Noel; D D Cataldo
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

7.  Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.

Authors:  Delphine Casabonne; Oscar Reina; Yolanda Benavente; Nikolaus Becker; Marc Maynadié; Lenka Foretová; Pierluigi Cocco; Anna González-Neira; Alexandra Nieters; Paolo Boffetta; Jaap M Middeldorp; Silvia de Sanjose
Journal:  Haematologica       Date:  2010-11-03       Impact factor: 9.941

8.  High doses of laser phototherapy can increase proliferation in melanoma stromal connective tissue.

Authors:  Lúcio Frigo; Joseli Maria Cordeiro; Giovani Marino Favero; Durnavei Augusto Maria; Ernesto Cesar Pinto Leal-Junior; Jon Joensen; Jan Magnus Bjordal; Denise Carvalho Roxo; Rodrigo Labat Marcos; Rodrigo Alvaro Brandão Lopes-Martins
Journal:  Lasers Med Sci       Date:  2018-04-05       Impact factor: 3.161

9.  SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.

Authors:  Jenna D Lovaas; Lijia Zhu; Christine Y Chiao; Vanessa Byles; Douglas V Faller; Yan Dai
Journal:  Prostate       Date:  2012-10-04       Impact factor: 4.104

10.  Bone marrow-derived myofibroblasts are the providers of pro-invasive matrix metalloproteinase 13 in primary tumor.

Authors:  Julie Lecomte; Anne Masset; Silvia Blacher; Ludovic Maertens; André Gothot; Marie Delgaudine; Françoise Bruyère; Oriane Carnet; Jenny Paupert; Martin Illemann; Jean-Michel Foidart; Ida K Lund; Gunilla Høyer-Hansen; Agnes Noel
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.